Position
Creative Planning in Arcutis Biotherapeutics, Inc.
Back to the book · All holders of ARQT
Estimated mark uses implied 13F prices (value ÷ shares). Adds are treated as happening at this quarter’s mark; cuts at last quarter’s. Share jumps can be splits, not buys. This is not realized P&L.
Latest estimated mark −$148.9K$29.04 → $23.56
| Quarter | Shares | Value | Implied px | Est. mark | Flow | Weight |
|---|---|---|---|---|---|---|
| Q4 2025 | 27.2K | $788.9K | — | — | — | 0.0% |
| Q1 2026 | 29.7K | $698.6K | $23.56 | −$148.9K | $58.5K | 0.0% |